相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis
Amr Shaaban Hanafy et al.
VASCULAR PHARMACOLOGY (2019)
Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis
Carlos Noronha Ferreira et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis
Nicolas M. Intagliata et al.
GASTROENTEROLOGY (2019)
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Ethan M. Weinberg et al.
SEMINARS IN LIVER DISEASE (2019)
Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial
Dou-Sheng Bai et al.
INTERNATIONAL JOURNAL OF SURGERY (2019)
Vascular Targets for the Treatment of Portal Hypertension
Ksenia Brusilovskaya et al.
SEMINARS IN LIVER DISEASE (2019)
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis
I. Pettinari et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double-blind, controlled trial
Hisashi Hidaka et al.
HEPATOLOGY RESEARCH (2018)
Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis
Yuko Nagaoki et al.
HEPATOLOGY RESEARCH (2018)
Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications
Jihyun Kwon et al.
THROMBOSIS RESEARCH (2018)
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function
Bernhard Scheiner et al.
WIENER KLINISCHE WOCHENSCHRIFT (2018)
Management of Coagulation and Anticoagulation in Liver Transplantation Candidates
Patrick Northup et al.
LIVER TRANSPLANTATION (2018)
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference: October 6th and 7th, 2017 Rome, Italy
N. M. Intagliata et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis
Marco Senzolo et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2018)
Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 Featured Updates to the NCCN Guidelines
Michael B. Streiff et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
CYP2C9 Genotype-DependentWarfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R-and S-Warfarin and Their Oxidative Metabolites
Darcy R. Flora et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Effective Prevention for Portal Venous System Thrombosis After Splenectomy: A Meta-Analysis
Xiao Zhang et al.
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES (2017)
The early prevention and treatment of PVST after laparoscopic splenectomy: A prospective cohort study of 130 patients
Yu-yuan Qian et al.
INTERNATIONAL JOURNAL OF SURGERY (2017)
Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation
N. M. Intagliata et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats
Federica Cerini et al.
JOURNAL OF HEPATOLOGY (2016)
Anticoagulation Therapy with Warfarin Versus Low-Dose Aspirin Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
Guo-Qing Jiang et al.
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES (2016)
Is Post-TIPS Anticoagulation Therapy Necessary in Patients with Cirrhosis and Portal Vein Thrombosis? A Randomized Controlled Trial
Zhu Wang et al.
RADIOLOGY (2016)
Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B
Shao-bo Cui et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Association between portal vein thrombosis and survival of liver transplant recipients: a systematic review and meta-analysis of observational studies
Journal of Gastrointestinal and Liver Diseases (2015)
Portal vein thrombosis in cirrhosis: Controversies and latest developments
Damian J. Harding et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
EASL Clinical Practice Guidelines: Vascular diseases of the liver
JOURNAL OF HEPATOLOGY (2015)
Unexpected disappearance of portal cavernoma on long-term anticoagulation
Gilberto Silva-Junior et al.
JOURNAL OF HEPATOLOGY (2014)
Optimizing Risk Stratification in Portal Vein Thrombosis after Splenectomy and its Primary Prophylaxis with Antithrombin III Concentrates and Danaparoid Sodium in Liver Cirrhosis with Portal Hypertension
Hirofumi Kawanaka et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)
Portomesenteric vein thrombosis after laparoscopic sleeve gastrectomy
Jose Salinas et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2014)
Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis
Jung Wha Chung et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2014)
Portal vein thrombosis in liver cirrhosis
Nao Kinjo et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Which Anticoagulant Drug Should Be Used to Treat Portal Vein Thrombosis in Patients With Chronic Liver Disease?
Edoardo G. Giannini et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Portal Vein Thrombosis after Partial Splenic Embolization in Liver Cirrhosis: Efficacy of Anticoagulation and Long-term Follow-up
Mingyue Cai et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein Thrombosis
Maria Gabriela Delgado et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis
Erica Villa et al.
GASTROENTEROLOGY (2012)
Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis
Marco Senzolo et al.
LIVER INTERNATIONAL (2012)
Natural Course of Extrahepatic Nonmalignant Partial Portal Vein Thrombosis in Patients with Cirrhosis
Angelo Luca et al.
RADIOLOGY (2012)
Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor
Alexander G. G. Turpie et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Enfermedad tromboembólica venosa y cirrosis hepática
M. J. García-Fuster et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2010)
Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: Is it necessary?
Marco Vivarelli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Vascular Disorders of the Liver
Laurie D. DeLeve et al.
HEPATOLOGY (2009)
Predictive value of D-dimer for portal vein thrombosis after portal hypertension surgery in hepatitis B virus-related cirrhosis
Mei-Hai Deng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation
C Francoz et al.
GUT (2005)
Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticoagulant therapy
B Condat et al.
HEPATOLOGY (2000)
分享论文
